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Summary To date, few cases of human joint infection caused by the Mycobacterium terrae
complex have been reported. Because M. terrae infection is a relatively uncommon problem, it
can bemistaken for a noninfectious inflammatory joint condition. Themost common presentation
ofM. terrae complex infection is tenosynovitis of the hand; infections in bones other than those of
the hands are rarely reported. Here, we describe a patient with arthritis of the knee caused byM.
terrae and review data from other cases reported in the medical literature.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
The Mycobacterium terrae complex includes M. triviale, M.
nonchromogenicum and M. terrae. Members of the M. ter-
rae complex are Runyon group III, non-pigmented, slow-
growing organisms. Despite the common opinion that M.
terrae complex isolates are nonpathogenic,1 these organ-
isms are occasionally identified in clinical diseases of joints,
tendons, lung, gastrointestinal tract and genitourinary
tract. The upper extremities are the most frequently
infected sites of the musculoskeletal system, but infections
in bones other than those of the hands are rarely reported..2* Corresponding author. Departments of Intensive Care Medicine,
Chi-Mei Medical Center, Yungkang, Tainan, Taiwan.
Tel.: +886 6 2812811; fax: +886 6 2828928.
E-mail address: chekim.tan@gmail.com (C.-K. Tan).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.09.002We describe here a patient with arthritis of the knee caused
by M. terrae and review data from other cases reported in
the medical literature.
Case report
The patient was a 31-year-old, HIV-seronegative man with a
history of methotrexate and systemic steroid treatment for
rheumatoid arthritis. In August 2005, he complained of pain
and stiffness in his right knee for about one week. He did not
recall any distinct trauma before the onset of his initial joint
lesions. He did not have fever, fatigue, anorexia, regional
adenopathy, respiratory or gastrointestinal symptoms, or
weight changes during the course of this illness. Physical
examination was unremarkable except for swelling, local
heat and tenderness over the right knee joint. Joint effusion
was palpated around the right knee. Movements of the rightPublished by Elsevier Ltd. All rights reserved.
Table 1 Characteristics of patients with infections in bones other than those of the hand due to Mycobacterium terrae complex.
Case
(Reference)
Age
(years); sex
No. of months with
symptoms before
diagnosis
Comorbid
condition(s)
Infected
site(s)
Corticosteroid
therapy
Outcome
1 (5) 0.5; M 0.75 None Hip None Cured
2 (6) 65; M 72 Not specified Ankle Injected Cured
3 (7) 57; M 3 Rheumatoid
arthritis
Knee Injected Improved
4 (8) 22; unknown 39 None Knee Injected Unknown
5 (present report) 31; M 3.5 Rheumatoid
arthritis
Knee Systemic Improved
e146 H.-W. Chen et al.knee were moderately limited in all directions. Laboratory
examination revealed elevated erythrocyte sedimentation
rate (ESR: 57 mm/h) and rheumatic factor (460 IU/ml); renal
and liver function tests, the level of uric acid and blood
counts were in the normal range.
Aspiration of joint effusion yielded 30 ml of serosangui-
nous fluid, but no crystals were found upon microscopic
examination. Gram stain and acid-fast stain were negative,
as were routine bacterial cultures. Analysis of the synovial
fluid revealed a white blood cell count of 9450/mm3, with
predominance of neutrophil (78%), total protein of 4.5 gm/
dl, LDH of 333 IU/l and glucose of 116 mg/dl. Aspirate was
inoculated onto Middlebrook 7H11 selective agar with anti-
microbials (BBL, Becton Dickinson, Sparks, MD, USA) and
BACTEC MGIT 960 system bottle (Becton-Dickinson Diagnostic
Instrument Systems, Sparks, MD, USA). Acid-fast bacilli (AFB)
stains were done on submission of the specimens and
repeated on positive cultures from a BACTEC system. Isolates
were identified to the species level using conventional bio-
chemical methods.3 A purified protein derivative (PPD)
tuberculosis skin test remained negative. After two months
of inoculation, the mycobacteria culture of synovial fluid
yielded a positive result. Antimicrobial therapy with rifatar
was given for possible tuberculous arthritis. However, the
clinical condition did not improve and the patient developed
a left knee effusion. The analysis of the fluid was similar to
the findings for the right knee. Three weeks later, it was
recognized that the first synovial fluid cultures had been
positive for M. terrae. The isolated organism grew at 37 8C
and showed nonpigmentation in both light and dark condi-
tions. There was no growth in 5% sodium chloride and on
MacConkey agar. There was a negative 3-day and positive 14-
day arylsulfatase test. It was negative for both urease and
pyrazinamidase, but positive for b-galactosidase, acid phos-
phatase, catalase (45 mm foam), thermostable catalase and
Tween 80 hydrolysis (10 days). The patient was then treated
with azithromycin (250 mg/daily), ethambutol (800 mg/
daily) and levofloxacin (750 mg/daily). Two months later,
the swelling and pain in the bilateral knee gradually
improved during follow-up in outpatient clinics. Finally, he
was successfully treated with the combined regimen for 12
months.
Discussion
M. terrae was first isolated by Richmond and Cummings in
1950 from radish washings.4 This organism is usuallydescribed as an occasionally isolated nonpathogenic colonizer.
To date, few cases of human joint infection caused by the M.
terrae complex have been reported. BecauseM. terrae infec-
tion is a relatively uncommonproblem, it can bemistaken for a
noninfectious inflammatory joint condition.Themost common
presentation ofM. terrae complex infection is tenosynovitis of
the hand. In most patients with infections of the upper extre-
mity, there was either a history of an antecedent puncture of
the hand or an occupation or hobby that could have increased
the risk of hand trauma and wound contamination.2 Persistent
or recurrent infectionwas reported in 21% of patients, and 10%
eventually underwent amputation.2
The infection of bones in the hip,5 ankle6 and knee7,8 was
rarely reported in the English literature. Details from four
cases and the case reported here are shown in Table 1. The
age of the patients ranged from 6months to 65 years (median
age, 31 years). Most patients had no predisposing condition
and were thought to be immunologically intact. Only two
patients had underlying disorders of rheumatoid arthritis.
Most of them had improvement or cure after treatment.. In
contrast to tenosynovitis of the hand, there was neither
apparent exposure history nor associated occupations or
hobbies (except one farmer).
The interval between the onset of symptoms and the
identification of the etiologic agent was 23.7  31.4 months
(the mean time  SD). Four of these five cases were treated
with corticosteroid, either injected locally or given systemi-
cally, before the diagnosis of infection was made. The long
interval between the onset of symptoms and the microbio-
logical identification of M. terrae, and the initial use of
corticosteroid therapy, suggests that the clinical presenta-
tion was often nonspecific and a noninfectious inflammatory
condition was suspected in most cases. The morbidity asso-
ciated with delayed diagnosis and the possible adverse
effects of corticosteroid therapy in untreated chronic infec-
tions underscore the importance of including M. terrae
infection (and other occult infections) in the differential
diagnosis of refractory arthritis that is thought to be of a
nonspecific inflammatory nature.
Our patient received macrolide and ethambutol for M.
terrae arthritis and had clinical improvement without any
sequelae. This is consistent with previous findings that
ethambutol and azithromycin are effective in vitro against
the M. terrae isolate tested.2 However, in vitro antibiotic
susceptibility testing for this mycobacterial isolate might be
worthwhile to refine the therapy, which might have to be
continued for a prolonged period to increase the possibility of
Mycobacterium terrae arthritis e147a cure and decrease the need for surgical intervention in such
a localized disease.
Our case is instructive for three reasons. First, in spite of
the rare occurrence of M. terrae arthritis of the lower
extremities, M. terrae should be considered as one possible
pathogen of joint infection, in either immunocompromised or
immunocompetent patients. Second, entertaining the pos-
sibility of an indolent mycobacterial infection in such cases
might reduce the inappropriate use of corticosteroid therapy
in the context of unsuspected infection. Finally, a multidrug
antibiotic regimen that includes a macrolide might be useful
in the management of such patients.
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